HC restrains Cipla from selling drug containing Indacaterol

Last Updated: Friday, January 9, 2015, 23:51

The court said the restraint on Cipla will remain till its application for compulsory license is decided by the relevant authority.

HC order 'disappointing', says Cipla

Last Updated: Friday, January 9, 2015, 23:10

Drug maker Cipla Friday expressed disappointment over the Delhi High Court order that restrained the company from manufacturing and selling any medicine containing 'Indacaterol', saying that the interim verdict would deny patients access to drugs they need.

Cipla among winners in $860 million South Africa aids drug tender

Last Updated: Wednesday, December 24, 2014, 20:57

Aspen Pharmacare was awarded a 2.5 billion contract, India`s Cipla a 2 billion deal, US-based Mylan won a 2.8 billion share and unlisted local firm Sonke got a 3 billion stake in the tender.

Cipla bags Rs 1,100 crore order from South African govt

Last Updated: Tuesday, December 23, 2014, 18:04

Drug major Cipla's subsidiary has bagged an order worth 2 billion rand (around Rs 1,100 crore) for HIV drugs from the South African government.

HC reserves order on Novartis-Cipla drug dispute

Last Updated: Wednesday, December 17, 2014, 21:32

The Delhi High Court has reserved its verdict on a dispute between pharma firms Novartis and Cipla over manufacturing of the drug Indacaterol, used for treatment of chronic obstructive pulmonary disease.

Novartis sues India's Cipla over respiratory drug Onbrez

Last Updated: Wednesday, December 17, 2014, 19:21

Swiss drugmaker Novartis AG said on Wednesday it had sued India`s Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug`s price.

Cipla's arm Meditab sells stake in Jiangsu for $18.5 mn

Last Updated: Wednesday, December 10, 2014, 14:39

The closing of the transaction is subject to receipt of applicable regulatory approvals in China, it added.

Meda and Cipla sue Apotex to enforce Dymista patents

Last Updated: Wednesday, December 3, 2014, 14:52

Sweden-based drug firm Meda Pharmaceuticals Inc and Cipla Ltd have "sued" Apotex Inc and Apotex Corp in Federal District Court in Delaware in US to enforce patents of its allergy drug 'Dymista'.

Cipla acquires Croatia-based Celeris

Last Updated: Thursday, December 5, 2013, 16:03

Drug major Cipla on Thursday said its wholly owned subsidiary has acquired Croatia based firm Celeris d.O.O, distributor of its products in that country.

Cipla ups stake in Ugandan firm, acquires 14.5% for $15 million

Last Updated: Thursday, November 21, 2013, 15:17

Pharma firm Cipla Ltd on Thursday said it has gained majority stake in Uganda-based Quality Chemical Industries Ltd with the acquisition of additional 14.5 per cent stake for USD 15 million.

Cipla chief calls for ‘obligatory’ drugs licenses

Last Updated: Friday, August 16, 2013, 21:44

The chairman of India’s oldest pharmaceutical firm Cipla has asked the Indian government to push for "obligatory licensing" of drugs to improve access to essential medicines in the Third World.

Morgan Stanley downgrades Cipla to "underweight"

Last Updated: Tuesday, August 13, 2013, 14:57

Morgan Stanley downgraded Cipla Ltd to "underweight" from "equal-weight" and reduces its target price on the stock to Rs 386 from Rs 414 citing slower growth prospects and valuations.